Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07028255

Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels

Effectiveness of Qualia Testosterone Supplementation on Testosterone Levels: A Randomized Double-Blind Parallel Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Qualia Life Sciences · Industry
Sex
Male
Age
28 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a randomized, double-blind, placebo-controlled parallel trial designed to assess the efficacy of Qualia Testosterone, a novel dietary supplement, in adult males aged 28 to 65 experiencing symptoms associated with testosterone deficiency. Approximately 60 participants will be randomized to receive either Qualia Testosterone (2 capsules daily) or a matched placebo for 21 days, with dosing administered each morning. The study's primary outcomes are changes in total testosterone, free testosterone (via dialysis), and dihydrotestosterone levels from baseline to Week 3. Secondary outcomes include changes in Aging Male Symptoms Scale scores-encompassing psychological, somatic, and sexual domains-as well as safety and tolerability. Blood samples will be collected in a laboratory setting, while symptom and safety assessments will be completed electronically at home.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTQualia TestosteroneQualia Testosterone manufactured by Qualia Life Sciences
DIETARY_SUPPLEMENTPlaceboRice Flour

Timeline

Start date
2025-07-01
Primary completion
2025-09-01
Completion
2025-10-01
First posted
2025-06-19
Last updated
2025-06-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07028255. Inclusion in this directory is not an endorsement.